Next generation in-blood glucose monitoring using non-invasive optoacoustic sens...
"GLUMON aims to leverage a new class of a biomedical optoacoustic sensor developed under the FETOpen project RSENSE (GA #862811) and offer the next generation of non-invasive biochemical in-vivo sensing. The preliminary sensor for...
"GLUMON aims to leverage a new class of a biomedical optoacoustic sensor developed under the FETOpen project RSENSE (GA #862811) and offer the next generation of non-invasive biochemical in-vivo sensing. The preliminary sensor for non-invasive in-blood glucose sensing has already produced outstanding findings and places the technology well ahead of its competition. Addressing the limitations of existing sensors, mainly accurate non-invasive continuous monitoring of blood-glucose as well as comfort, the GLUMON sensor will better address diabetes healthcare needs. As a secondary goal and contingency plan, GLUMON will exploit this technology as a lipid sensor and build further potential by addressing the emerging precision nutrition market.The objectives of the GLUMON project are to:1) mature the technology from a lab bench-top setup to a functional portable sensor prototype;2) improve its market readiness level;3) validate and demonstrate the sensor in the lab as well as in preclinical and clinical settings;4) develop a sound business case and exploitation strategy; and5) address regulatory and ethical requirements for this medical device in preparation for the next phase.The GLUMON consortium includes the key developers of the technology, two SMEs for prototyping, quality control and tech-to-market transition, and two university clinical partners for sensor validation. Key stakeholders (type-2 diabetes patients, patient advocacy groups, clinicians, health insurance) will be involved during the project to assess user needs and market requirements. Overall, the GLUMON sensor has the potential to play a critical role in future medicine by improving diabetes management and, more generally, by promoting new healthcare concepts in obesity and metabolic diseases, including early disease detection and home-based disease monitoring."ver más
Seleccionando "Aceptar todas las cookies" acepta el uso de cookies para ayudarnos a brindarle una mejor experiencia de usuario y para analizar el uso del sitio web. Al hacer clic en "Ajustar tus preferencias" puede elegir qué cookies permitir. Solo las cookies esenciales son necesarias para el correcto funcionamiento de nuestro sitio web y no se pueden rechazar.
Cookie settings
Nuestro sitio web almacena cuatro tipos de cookies. En cualquier momento puede elegir qué cookies acepta y cuáles rechaza. Puede obtener más información sobre qué son las cookies y qué tipos de cookies almacenamos en nuestra Política de cookies.
Son necesarias por razones técnicas. Sin ellas, este sitio web podría no funcionar correctamente.
Son necesarias para una funcionalidad específica en el sitio web. Sin ellos, algunas características pueden estar deshabilitadas.
Nos permite analizar el uso del sitio web y mejorar la experiencia del visitante.
Nos permite personalizar su experiencia y enviarle contenido y ofertas relevantes, en este sitio web y en otros sitios web.